TGFB1 and neoplasm: Curcumin was found to prevent tumor-induced loss of T-effector cells, reverse type-2 cytokine bias and blocks T-regulatory cell augmentation in tumor-bearing hosts via down-regulation of TGF-β in cancer cells (unpublished data).